Evogene Ltd
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Evogene Ltd
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment, followed by Industry.
/ 
Frequently asked questions
To buy Evogene Ltd stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Evogene Ltd by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Evogene Ltd is EVGN:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Evogene Ltd has its primary listing on NASDAQ. You can trade Evogene Ltd with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Evogene Ltd is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Evogene Ltd as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Evogene Ltd.